Spontaneous development of plasmacytoid tumors in mice with defective fas-fas ligand interactions

Journal of Experimental Medicine

Volumn 187, Issue 11, 1998, Pages 1825-1838

  Davidson, Wendy F ^a,b   Giese, Thomas ^a   Fredrickson, Torgny N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOLLAND LABORATORY   (United States)

Author keywords

Fas; Fas ligand; Gld; Lpr; Lymphoma

Indexed keywords

ANIMAL CELL; ARTICLE; CELL DEATH; LIGAND BINDING; MALIGNANT TRANSFORMATION; MOLECULAR INTERACTION; MOUSE; MUTAGENESIS; NONHUMAN; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN FAMILY; T LYMPHOCYTE SUBPOPULATION;

AGING; ANIMALS; ANTIGENS, CD95; B-LYMPHOCYTE SUBSETS; FAS LIGAND PROTEIN; LEUKEMIA VIRUS, MURINE; LYMPHOMA, SMALL-CELL; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED MRL LPR; MICE, SCID; PHENOTYPE; PROVIRUSES; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

EID: 0032101118     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.11.1825     Document Type: Article

References (67)

1. Watanabe-Fukunada, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature. 356:314-317.
2. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 76:969-976.
3. Adachi, M., R. Watanabe-Fukunaga, and S. Nagata. 1993. Aberrant transcription caused by insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl. Acad. Sci. USA. 90:1756-1760.
4. Suda, T., T. Takahashi, P. Goldstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1169-1178.
5. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1756.
6. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzku, V. Moeller, W. Falk, K.M. Debatin, and P.M. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science. 245:301-304.
7. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas ligand that induces apoptosis. J. Exp. Med. 179: 873-879.
8. Itoh, N., S. Yonehara, A. Ishi, M. Yonehara, S.-I. Mizushima, M. Samechmia, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide coded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:233-243.
9. Cohen, P.L., and R.A. Eisenberg. 1991. lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
10. Sneller, M.C., S.E. Straus, E.S. Jaffe, J.S. Jaffe, Y.A. Fleisher, M. Stetler-Stevenson, and W.A. Strober. 1992. A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J. Clin. Invest. 90:334-341.
11. Fisher, G.H., F.J. Rosenberg, S.E. Straus, J.K. Dale, L.A. Middleton, A.Y. Lin, W. Strober, M.J. Lenardo, and J.M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative sydrome. Cell. 81:935-946.
12. Rieux-Laucaut, F., F. LeDiest, C. Hivroz, I.A.G. Roberts, K.M. Debatin, A. Fischer, and J.P. de Villartay. 1995. Mutations in Fas associated human lymphoproliferative syndrome and autoimmunity. Science. 268:1347-1349.
13. Bettinardi, A., D. Brugnoni, E. Quiros-Roldan, A. Malagoli, S. La Grutta, A. Correra, and L.D. Notarangelo. 1997. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome. Blood. 89:902-909.
14. Drappa, J., A.K. Vaishaw, K.E. Sullivan, J.-L. Chu, and K.B. Elkon. 1996. Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N. Engl. J. Med. 335:1643-1649.
15. Davidson, W.F., F.J. Dumont, H.G. Bedigian, B.J. Fowlkes, and H.C. Morse. 1986. Phenotypic, functional, and molecular genetic comparisons of the abnormal lymphoid cells in C3H-lpr/lpr and C3H-gld/gld mice. J. Immunol. 136:4043-4054.
16. + double negative T cells as the predominant populations in enlarged lymph nodes. J. Immunol. 154:4986-4995.
17. Maldonado, M.A., R.A. Eisenberg, E. Roper, P.L. Cohen, and B.L. Kotzin. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatability complex class I.J. Exp. Med. 181:641-648.
18. + cells in lpr/lpr mice lacking β2 microglobulin. J. Immunol. 154:2063-2074.
19. Christianson, G.J., R.L. Blankenburg. T.M. Duffy, D. Panka, J.B. Roths, A. Marshak-Rothstein, and D.C. Roopenian. 1996. Beta-2-microglobulin dependence of the autoimmune syndrome of MRL-lpr mice. J. Immunol. 156: 4932-4939.
20. + T cells. J. Immunol. 146:4138-4148.
21. Dumont, F.J., R.C. Habbersett, and L.Z. Coker. 1985. Subsets of Lyt-2 cells defined by differential expression of the 9F3 antigen: alterations in mice of the lpr/lpr genotype. J.Immunol. 134:196-203.
22. Giese, T., and W.F. Davidson. 1992. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for Ipr. J. Immunol. 149:3097-3106.
23. Budd, R.C., J.H. Schumacher, G. Winslow, and T.R. Mossman. 1991. Elevated production of interferon-γ and interleukin 4 by mature T cells from autoimmune lpr mice correlates with Pgp-1 (CD44) expression. Eur. J. Immunol. 21: 1081-1084.
24. Reap, E.A., M.L. Piecyk, A. Oliver, E.S. Sobel, T. Waldschmidt, P.L. Cohen, and R.A. Eisenberg. 1996. Phenotypic abnormalities of splenic and bone marrow B cells in lpr and gld mice. Clin. Immunol. Immunopath. 78:21-29.
25. Russell, J.H., B. Rush, C. Weaver, and R. Wang. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Int. Acad. Sci. USA. 90:44119-4413.
26. Russell, J.H., and R. Wang, 1993. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur. J. Immunol. 23:2379-2382.
27. Erikson, J.M., Z. Radic, S.A. Camper, R.R. Hardy, C. Carmack, and M. Weigert. 1991. Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice. Nature. 349:331-334.
28. Roark, J.H., C.L. Kuntz, K.-A. Nguyen, A.J. Caton, and J. Erikson. 1995. Breakdown of B cell tolerance in a mouse model of systemic lupus erythematosus. J. Exp. Med. 181: 1157-1167.
29. Rathmell, J.C., and C.C. Goodnow. 1994. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells J. Immunol. 153:2831-2842.
30. Marcu, K.B., J. Banerji, N.A. Penncavage, R. Lang, and N. Arheim. 1980. 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell. 22:187-196.
31. Coleclough, C., R.P. Perry, K. Karjalainen, and M. Weigert. 1981. Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression. Nature. 290:372-378.
32. Hedrick, S.M., E.A. Nielson, J. Kavalier, D.L. Cohen, and M.M. Davis. 1984. Sequence relationships between putative T-cell receptor polypeptides and immunoglobulins. Nature. 308:153-158.
33. Chattopadhyay, S.K., M.R. Lander, E. Rands, and D.R. Lowy. 1980. Structure of endogenous murine leukemia virus DNA in mouse genomes. Prof. Natl. Acad. Sci. USA. 77: 5774-5778.
34. Huppi, K., D. Siwarski, R. Skurla, D. Klinman, and J.F. Mushinski. 1990. Pvt-1 transcripts are found in normal tissues and are altered by reciprocal (6; 15) translocations in mouse plasmacytomas. Prof. Natl. Acad. Sci. USA. 87:6964-6968.
35. Jacobson, B.A., D.J. Panka, K.-A. Nguyen, J. Erikson, A.K., Abbas, and A. Marshak-Rothstein. 1995. Anatomy of autoantibody production; dominant localization of antibody-producing cells to T cell zones in Fas-deficient mice. Immunity. 3:509-519.
36. Potter, M., and F. Wiener. 1992. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis. 13:1681-1697.
37. Jonkers, J., and A. Berns. 1996. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochem. Biophys. Acta. 1287:29-57.
38. Stoye, J., and J. Coffin. 1990. Endogenous Viruses. In RNA Tumor Viruses. 2nd edition. R. Weiss, N. Teich, H. Varmus, and J. Coffin, editors. Cold Spring Harbor Press, Cold Spring Harbor, NY. 357-404.
39. Phillips, J., K. Mehta, C. Fernandez, and E. Raveche. 1992. The NZB mouse as a model for CLL. Cancer Res. 52:437-443.
40. Magrath, I. 1992. Molecular basis of lymphomagenesis. Cancer Res. 52(Suppl.):5529-5540.
41. Penn, I. 1986. The occurrence of malignant tumors in immunosuppressed individuals. Prog. Allergy. 37:259-300.
42. Morse, H.C., J.W. Hartley, Y. Tang., S. Chattopadhyay, N. Giese, and T.N. Fredrickson. 1994. Lymphoproliferation as a precursor to neoplasia: what is a lymphoma? In Viruses and Cancer. A. Minson, J. Neil, and M. McCrae, editors. Cambridge University Press, 265-291.
43. Wotherspoon, A.C., C. Ortiz Hidalgo, M.R. Falzon, and P.G. Isaacson. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 338:1175-1176.
44. Parsonnet, J., S. Hansen, L. Rodriguez, A.B. Gelb, R.A. Warnke, E. Jellum, N. Orentreich, J.H. Vogelman, and G.D. Friedman. 1994. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med. 330:1267-1271.
45. Peng, S.L., M.E. Robert, A.C. Hayday, and J. Craft. 1996. A tumor-suppressor function for Fas (CD95) revealed in T cell-deficient mice. J. Exp. Med. 184:1149-1154.
46. Jelinek, D. F., and P.E. Lipsky. 1987. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α and interleukin 1. J. Immunol. 139:2970-2976.
47. Finkelman, F.D., I.M. Katona, T.R. Mosmann, and R.L. Coffman. 1988. IFN-γ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140: 1022-1027.
48. Coffman, R.L., B.W.P. Seymour, D.A. Lebman, D.D. Hiraki, J. Christiansen, B. Shrader, H.M. Cherwinski, H.F.J. Savelkoul, F.D. Finkelman, M.W. Bond, and T.R. Mossman. 1988. The role of helper T cell products in mouse B cell differentiation and isotype regulation. Immunol. Rev. 102: 5-30.
49. Go, N.F., B.E. Castle, R. Barrett, R. Kastelein, W. Dang, T.R. Mossman, K.W. Moore, and M. Howard. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625-1631.
50. + double negative T cells express CD28 and respond to costimulation with PMA and antibodies to CD28 J. Immunol. 151:597-609.
51. Thoman, M.L., and W.O. Weigle. 1989. The cellular and subcellular bases of immunosenescence. Adv. Immunol. 46: 221-261.
52. Miller, R.A. 1991. Aging and immune function. Int. Rev. Cytol. 124:187-215.
53. Zhou, T., C.K. Edwards III, and J.M. Mountz. 1995. Prevention of age-related T cell apoptosis detect in CD2-fas-transgenic mice. J. Exp. Med. 182:129-137.
54. Herndier, B.G., L.D. Kaplan, and M.S. McGrath. 1994. Pathogenesis of AIDS lymphomas. AIDS 8:1025-1049.
55. Filipovich, A.H., R. Shapiro, L. Robison, A. Mettens, and G. Frizzera. 1990. Lymphoproliferative disorders associated with immunodeficiency. In The Non-Hodgkin's Lymphomas. J.T. McGrath, editor. Arnold Press, London. 135-154.
56. Grufferman, S. 1996. Epidemiology and hereditary aspects of malignant lymphoma and Hodgkin's disease. In Neoplastic Diseases of the Blood. Third edition. P.H. Wiernik, G.P. Canellos, J.P. Dutcher, and K.A. Kyle, editors. Churchill Livingstone, New York.737 pp.
57. Morse, H.C., S. Chattopadhyay, M. Makino, T.N. Fredrickson, A.W. Hugin, and J.W. Hartley. 1992. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS 6:607-621.
58. Tang, Y., S. Chattopadhyay, J.W. Hartley, T.N. Fredrickson, and H.C. Morse. 1994. Clonal outgrowths of T and B cells in scid mice reconstituted with cells from mice with MAIDS. In Vivo. 8:953-960.
59. Radl, J. 1990. Age-related monoclonal gammopathies: clinical lessons from the aging C57BL mouse. Immunol. Today. 11:234-236.
60. Radl, J., Y. Punt, M.H. van den Enden-Vieveen, P. Bentvelzen, M.H.C. Bakkus, Th.W. van den Akker, and R. Benner. 1990. The 5T mouse multiple myeloma model: absence of c-myc oncogene rearrangement in early transplant generations. Br. J. Cancer. 61:276-278.
61. Lin, A., J. Dale, T. Fleisher, G. Fisher, F. Rosenberg, M. Lenardo, J. Puck, L. Middleton, B. Corden, M. Tucker, and S. Straus. 1995. Familial aggregation of Hodgkin's disease (HD), and autoimmune lymphoproliferative syndrome (ALPS) and germline Fas mutations. Blood. 86(Suppl. 1):271a. (Abstr.)
62. Landowski, T.H., N. Qu, I. Buyuksal, J.S. Painter, and W.S. Dalton. 1997. Mutations in the Fas antigen in patients with multiple myeloma. Blood. 90:4266-4270.
63. Zornig, M., A. Grzeschiczek, M-B. Kowalski, K.-U. Hartmann, and T. Moroy. 1995. Loss of Fas/Apo-1 receptor accelerates lymphomagenesis in EμL-myc transgenic mice but not in animals infected with MoMuLV. Oncogene. 10:2397-2401.
64. Moroy, T., A. Grzesschiczek, S. Petzold, and K.-U. Hartman. 1993. Expression of a pim-1 transgene accelerates lymphoproliferation and inhibits apoptosis in lpr/lpr mice. Proc. Natl. Acad. Sci. USA. 90:10734-10738.
65. Peters, K.L., L.S. Rabstein, R.M. Spahn, R.M. Madison, and R.J. Huebner. 1972. Incidence of spontaneous neoplasms in breeding and retired breeder BALB/cCr mice throughout the natural lifespan. Int. J. Cancer. 10:273-282.
66. Akamatsu, Y., and B.P. Barton. 1974. Neoplasms and amyloidosis in strains of mice treated with 3-methylcholanthrene. J. Natl. Cancer Inst. 52:377-385.
67. Morse, H.C. III, J.B. Roths, W.F. Davidson, W.Y. Langdon, T.N. Fredrickson, and J.W. Hartley. 1985. Abnormalities induced by the mutant gene. lpr. Patterns of disease and expression of murine leukemia viruses in SJL/J mice homozygous and heterozygous for lpr. J. Exp. Med. 161:602-616.